What is a stock summary page? Click here for an overview.
AbbVie Inc (NYSE:ABBV) Stock News, Headlines & Updates
AbbVie Inc Stock News from GuruFocus
- 1
- 2
- 3
Apr 26, 2025
AbbVie Inc (ABBV) Q1 2025 Earnings Call Highlights: Strong Growth in Immunology and Neuroscience Drive Revenue Surge
GuruFocus News • 1:04am
Q1 2025 AbbVie Inc Earnings Call Transcript
GuruFocus News • 11:10pm
Apr 25, 2025
AbbVie (ABBV) Stock Jumps on Strong Earnings and Raised Guidance
GuruFocus News • 4:25pm
AbbVie (ABBV) Boosts Revenue Forecast Amid Strong Q1 Results
GuruFocus News • 11:57am
AbbVie (ABBV) Surges on Strong Psoriasis Treatment Sales
GuruFocus News • 8:55am
Company Plans Over $10 Billion Investment in U.S. Growth Strategy | ABBV Stock News
GuruFocus News • 8:45am
Alphabet (GOOGL) Boosts Tech Sector as Market Momentum Faces Challenges | ABBV Stock News
GuruFocus News • 8:15am
AbbVie Inc (ABBV) Reports Strong First-Quarter 2025 Financial Results | ABBV stock news
GuruFocus News • 8:07am
AbbVie (ABBV) Surpasses Earnings and Revenue Estimates
GuruFocus News • 7:58am
AbbVie (ABBV) Surpasses Q3 Earnings and Revenue Expectations
GuruFocus News • 7:58am
AbbVie (ABBV) Boosts Profit Outlook Amid Strong Q1 Performance
GuruFocus News • 7:57am
AbbVie (ABBV) Revises 2025 EPS Guidance Amid Acquisition Costs | ABBV Stock News
GuruFocus News • 7:29am
AbbVie (ABBV) Surpasses Q1 Revenue Expectations with Strong Performance | ABBV Stock News
GuruFocus News • 7:29am
AbbVie Reports First-Quarter 2025 Financial Results | ABBV Stock News
GuruFocus News • 7:15am
AbbVie Inc (ABBV) Q1 2025 Earnings: EPS of $2.46 Beats Estimate, Revenue Hits $13.343 Billion
GuruFocus News • 7:15am
AbbVie (ABBV) Surpasses Q1 Earnings Forecasts and Raises 2025 Guidance
GuruFocus News • 7:01am
AbbVie Reports First-Quarter 2025 Financial Results
PRNewswire • 7:00am
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Cerevel Therapeutics Holdings, Inc. Lawsuit - ABBV
PRNewswire • 5:00am
Apr 24, 2025
AbbVie (ABBV) and Other Key Companies Set to Report Earnings | ABBV Stock News
GuruFocus News • 2:16pm
Lost Money on Cerevel Therapeutics Holdings, Inc.(ABBV)? Join Class Action Suit Seeking Recovery -- Contact Levi & Korsinsky
Marketwired • 12:00pm
AbbVie (ABBV) Preps for Q1 2025 Earnings Amid Cautious Outlook
GuruFocus News • 10:59am
AbbVie (ABBV) Seeks FDA Approval for New Wrinkle Treatment TrenibotE
GuruFocus News • 8:59am
AbbVie Submits BLA for TrenibotE to FDA for Glabellar Lines Treatment | ABBV stock news
GuruFocus News • 8:12am
AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines
PRNewswire • 8:00am
AbbVie (ABBV) Submits FDA Application for New Facial Aesthetic Treatment | ABBV Stock News
GuruFocus News • 7:51am
AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines | ABBV Stock News
GuruFocus News • 7:48am
The Gross Law Firm Reminds Cerevel Therapeutics Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - ABBV
PRNewswire • 5:00am
Apr 23, 2025
Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations -- Investors Should Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights -- ABBV
Marketwired • 1:00pm
Apr 22, 2025
AbbVie (ABBV) Initiated at Overweight by Cantor Fitzgerald with $210 Price Target | ABBV Stock News
GuruFocus News • 6:34am
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc.(ABBV) Shareholders
PRNewswire • 5:00am
Apr 21, 2025
Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for Investors -- Contact Levi & Korsinsky
Marketwired • 1:00pm
BofA Adjusts AbbVie (ABBV) Price Target Ahead of Q1 Results | ABBV Stock News
GuruFocus News • 6:17am
The Gross Law Firm Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ABBV
PRNewswire • 5:00am
Apr 18, 2025
Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations -- Investors Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights -- ABBV
Marketwired • 1:00pm
Shareholders that lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
PRNewswire • 5:00am
Apr 17, 2025
Investors who lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) should contact The Gross Law Firm about pending Class Action - ABBV
Marketwired • 1:00pm
ABBV LAWSUIT ALERT: The Gross Law Firm Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PRNewswire • 5:00am
Apr 14, 2025
Piper Sandler Projects Strong Growth for Lenz Therapeutics (LENZ) with LNZ100 | ABBV Stock News
GuruFocus News • 6:17am
Apr 10, 2025
ABBV Stock Upgraded to Buy Amid Valuation Insights
GuruFocus News • 11:56am
Apr 09, 2025
AbbVie Inc (ABBV) Trading Down 4.25% on Apr 9
GuruFocus News • 12:05pm
- 1
- 2
- 3
Show
Entries
Headlines
Total 0- 1
No recent news